Day 1 – Thursday, December 5, 2019 Meet-the-Expert Breakout Session
Select one Meet-the-Expert Breakout Session for each day. Please note: Session attendance is limited and will be on a first-come, first-served basis. Thursday, December 5 Day 1: Investigational Antiretroviral Drugs and Strategies Day 1: Substance Abuse and HIV Infection Day 1: Managing Older Patients with HIV Infection Day 1: Managing HIV Infection Among Transgender (more…)
Day 2 – Friday, December 6, 2019 Meet-the-Expert Breakout Session
Select one Meet-the-Expert Breakout Session for each day. Please note: Session attendance is limited and will be on a first-come, first-served basis. Friday, December 6 Day 2: Antiretroviral Therapy: Managing Treatment Failure Day 2: Preexposure Prophylaxis (PrEP) Day 2: Renal Disease in HIV Infection Day 2: Neurocognitive Disorders in HIV Day 2: Management and (more…)
Day 3 – Saturday, December 7, 2019 Meet-the-Expert Breakout Session
Select one Meet-the-Expert Breakout Session for each day. Please note: Session attendance is limited and will be on a first-come, first-served basis. Saturday, December 7 Day 3: Antiretroviral Therapy: Managing Treatment Failure Day 3: Diagnosing and Treating Chlamydia and Gonorrhea Day 3: Neurocognitive Disorders in HIV Day 3: Ending the HIV Epidemic – (listening (more…)
Simplifying Antiretroviral Therapy: Two-Drug Regimens and Long-Acting Treatment
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity as part of a nationwide continuing medical education (CME) effort for physicians on the evolving challenges of managing HIV disease. This webinar will discuss the goals of antiretroviral therapy in people living with HIV (PLWH) who are currently in care and are successfully treated. Further, (more…)
HCV Post-Cure Monitoring and Management
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians. This webinar will cover the issues that persist after hepatitis C virus (HCV) infection cure and how practitioners can determine which patients should be monitored (more…)
Update on HIV Cure Research and Antiretroviral Drugs and Strategies, and a Personal Experience with COVID-19
TIME: 4:00 PM ET; 3:00 PM CT; 2:00 PM MT; 1:00 PM PT Use this tool to calculate the time of the webinar in your location. Assessment of Needs Rapid advances in HIV disease management require the ongoing attention of practitioners involved in HIV medicine. This course will address the implications of new information on (more…)
Update on HIV Cure Research and Antiretroviral Drugs and Strategies, and a Personal Experience with COVID-19
March 17, 2020: As you know, many agencies and institutions have banned travel and attending meetings, and many infectious disease physicians are urgently needed to care for patients with COVID-19. With your feedback from the survey we sent out on Tuesday and the World Health Organization declaring COVID-19 a pandemic, we have decided to postpone (more…)
Update on HIV Cure Research and Antiretroviral Drugs and Strategies, and a Personal Experience with COVID-19
TIME: 4:00 PM ET; 3:00 PM CT; 2:00 PM MT; 1:00 PM PT Use this tool to calculate the time of the webinar in your location. Assessment of Needs Rapid advances in HIV disease management require the ongoing attention of practitioners involved in HIV medicine. This course will address the implications of new information on (more…)
The Elements of Taking a Sexual History
The March 31, 2020, IAS-USA Webinar titled, The Elements of Taking a Sexual History, which was to be presented by Dr Allison Agwu, is postponed. While you wait for this webinar to be rescheduled, you may view the following webcast presented by Dr Agwu regarding sexual health here. A number of our faculty members (more…)
CROI 2020 Update: Prevention and Epidemiology
Overview Assessment of Needs This webinar will highlight successes and challenges in the control of the HIV epidemic globally and explore risk factors for HIV infection among vulnerable populations. New strategies for HIV prevention will be described, including advances in HIV testing, novel agents for pre- and postexposure prophylaxis, microbicides, and combination prevention. Learning Objectives (more…)